[1]
Fasano, M. et al. 2014. Cost-effectiveness of tenofovir in the treatment of patients with chronic hepatitis B: data from literature. Farmeconomia. Health economics and therapeutic pathways. 15, 1 (Mar. 2014), 15–26. DOI:https://doi.org/10.7175/fe.v15i1.908.